Clinical trial
Prospective, Placebo-controlled Study on the Functional and Quality of Life Effects of the Mollii Neuromodulatory Suit in Patients With Stroke and Multiple Sclerosis
NCT07333222 is registered in ClinicalTrials.gov with Somogy Megyei Kaposi Mór Teaching Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Placebo-controlled Study on the Functional and Quality of Life Effects of the Mollii Neuromodulatory Suit in Patients With Stroke and Multiple Sclerosis
- Lead sponsor
- Somogy Megyei Kaposi Mór Teaching Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 12, 2026
- Completion date
- August 1, 2028
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.